Author: Crawford Michael H.
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.9, Iss.1, 2009-01, pp. : 1-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Spironolactone "safer first-line" therapy for hypertension
Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. :
-Blockers: "not appropriate" first-line therapy for hypertension
Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. :